Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?

Warren Buffett's holding company Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has been able to produce jaw-dropping gains for its shareholders over the years by adhering to three basic principles:


Warren Buffett's holding company Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has been able to produce jaw-dropping gains for its shareholders over the years by adhering to three basic principles:

Warren Buffett. Image source: The Motley Fool.

But even Berkshire Hathaway hasn't been able to escape the ravages of the marketwide meltdown over the COVID-19 coronavirus. This indiscriminate wave of selling, though, is undoubtedly creating some once-in-a-lifetime buying opportunities for patient investors. Within Warren Buffett's own portfolio, for instance, the healthcare giants Biogen (NASDAQ: BIIB), Johnson & Johnson (NYSE: JNJ), and Teva Pharmaceutical Industries (NYSE: TEVA) all appear to be trading at bargain basement prices after their steep declines over the past few weeks. Here's why. 

Continue reading


Source Fool.com

Like: 0
JNJ
Share

Comments

You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more